Daniel Barenboim, Parkinson's disease
GLP-1 drug fails to slow Parkinson's
We spend billions searching for the cures to chronic illnesses while neglecting research that could make the daily lives of ...
People with early-onset Parkinson’s face challenges different from those with traditional late-onset Parkinson’s.
A Huntsville-based biotechnology company has secured $10 million in funding to begin the trial of a new way to deliver medication to advanced Parkinson’s disease patients.
46mon MSN
Stuart Carrington, LCFA’s football development officer and manager of the England Parkinson’s Walking Football Team, flew to ...
Doctors and researchers say ping pong can help slow Parkinson's disease. The South County Recreation Center in Bixby hosts ...
Phil Parkinson faces a decision over his Wrexham squad after overseeing a record-breaking January transfer window. Co-owners ...
The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...
Traditional deep brain stimulation surgery can take up to 10 hours to complete, with the patient wide awake. This robotic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback